SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882095-22-000027
Filing Date
2022-11-02
Accepted
2022-11-02 17:02:58
Documents
81
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gild-20220930.htm   iXBRL 10-Q 3089276
2 CEO CERTIFICATION gildq32022ex311ceocertific.htm EX-31.1 8270
3 CFO CERTIFICATION gildq32022ex312cfocertific.htm EX-31.2 7799
4 SECTION 906 CERTIFICATIONS gildq32022ex32section906ce.htm EX-32 5906
  Complete submission text file 0000882095-22-000027.txt   12692306

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20220930.xsd EX-101.SCH 61162
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gild-20220930_cal.xml EX-101.CAL 109647
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gild-20220930_def.xml EX-101.DEF 290337
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20220930_lab.xml EX-101.LAB 728722
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20220930_pre.xml EX-101.PRE 473927
75 EXTRACTED XBRL INSTANCE DOCUMENT gild-20220930_htm.xml XML 3154683
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19731 | Film No.: 221355076
SIC: 2836 Biological Products, (No Diagnostic Substances)